Skip Navigation


Brain Advance Access originally published online on December 22, 2004
Brain 2005 128(2):345-355; doi:10.1093/brain/awh364
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
128/2/345    most recent
awh364v2
awh364v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Shen, X.-M.
Right arrow Articles by Engel, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, X.-M.
Right arrow Articles by Engel, A. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain Vol. 128 No. 2 © Guarantors of Brain 2004; all rights reserved

Subunit-specific contribution to agonist binding and channel gating revealed by inherited mutation in muscle acetylcholine receptor M3–M4 linker

Xin-Ming Shen1, Kinji Ohno1, Steven M. Sine2 and Andrew G. Engel1

1 Department of Neurology and Neuromuscular Research Laboratory and 2 Department of Physiology and Biophysics and Receptor Biology Laboratory, Mayo Clinic, Rochester, MN, USA

Correspondence to: Dr Andrew G. Engel, Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA E-mail: age{at}mayo.edu

We trace the cause of congenital myasthenic syndromes in two patients to mutations in the {varepsilon} subunit of the muscle acetylcholine receptor (AChR). Both patients harbour deletion of an asparagine residue in the {varepsilon} subunit ({varepsilon}N436del) at the C-terminus of the cytoplasmic loop linking the third (M3) and fourth (M4) transmembrane domains. The presence of a null mutation in the second allele of the {varepsilon} subunit shows that {varepsilon}N346del determines the phenotype. Endplate studies show markedly reduced expression of the {varepsilon}N346del-AChR and compensatory accumulation of fetal {gamma}-AChR. Expression studies in HEK cells reveal decreased expression of {varepsilon}N436del-AChR and abnormally brief channel openings. Thus, neuromuscular transmission is compromised by AChR deficiency, fast channel kinetics of the {varepsilon}N346del-AChR and incomplete phenotypic rescue by {gamma}-AChR. Single-channel kinetic analysis shows that the {varepsilon}N436del shortens channel openings by reducing stability of the diliganded receptor: rates of channel closing and of ACh dissociation are increased and the rate of channel opening is decreased. In addition to shortening the M3–M4 loop, {varepsilon}N436del shifts a negatively charged aspartic acid residue adjacent to M4; the effects of {varepsilon}N436del are shown to result from shortening of the M3–M4 loop and not from juxtaposition of a negative charge to M4. To determine whether the consequences of {varepsilon}N346del are subunit-specific, we deleted residues that align with {varepsilon}N436 in ß, {delta} and {alpha} subunits. Each deletion mutant reduces AChR expression, but whereas the ß and {delta} mutants curtail channel open duration, the {alpha} mutant strikingly prolongs open duration. Kinetic analysis reveals that the {alpha} mutant increases the stability of the diliganded receptor: rates of channel closing and of ACh dissociation are decreased and the rate of channel opening is increased. The overall studies reveal subunit asymmetry in the contributions of the M3–M4 loops in optimizing AChR activation through allosteric links to the channel and the agonist binding site.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W.-y. Lo, E. J. Botzolakis, X. Tang, and R. L. Macdonald
A Conserved Cys-loop Receptor Aspartate Residue in the M3-M4 Cytoplasmic Loop Is Required for GABAA Receptor Assembly
J. Biol. Chem., October 31, 2008; 283(44): 29740 - 29752.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. S. Muller, S. K. Baumeister, U. Schara, J. Cossins, S. Krause, M. v. d. Hagen, A. Huebner, R. Webster, D. Beeson, H. Lochmuller, et al.
CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn
Brain, October 1, 2006; 129(10): 2784 - 2793.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.